ATE306273T1 - Verwendung von tiludronsäure beim geflügel zur herstellung eines arzneimittels zur prophylaxe und behandlung von osteoporose - Google Patents

Verwendung von tiludronsäure beim geflügel zur herstellung eines arzneimittels zur prophylaxe und behandlung von osteoporose

Info

Publication number
ATE306273T1
ATE306273T1 AT01400068T AT01400068T ATE306273T1 AT E306273 T1 ATE306273 T1 AT E306273T1 AT 01400068 T AT01400068 T AT 01400068T AT 01400068 T AT01400068 T AT 01400068T AT E306273 T1 ATE306273 T1 AT E306273T1
Authority
AT
Austria
Prior art keywords
poultry
osteoporosis
medicinal product
prophylaxis
treatment
Prior art date
Application number
AT01400068T
Other languages
English (en)
Inventor
Thierry Bardon
Dominique Thibaud
Original Assignee
Ceva Sante Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale filed Critical Ceva Sante Animale
Application granted granted Critical
Publication of ATE306273T1 publication Critical patent/ATE306273T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01400068T 2000-01-12 2001-01-11 Verwendung von tiludronsäure beim geflügel zur herstellung eines arzneimittels zur prophylaxe und behandlung von osteoporose ATE306273T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0000356A FR2803521B1 (fr) 2000-01-12 2000-01-12 Utilisation de l'acide tiludronique et de ses derives chez la volaille pour la preparation d'un medicament destine a prevenir et a traiter l'osteoporose

Publications (1)

Publication Number Publication Date
ATE306273T1 true ATE306273T1 (de) 2005-10-15

Family

ID=8845841

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01400068T ATE306273T1 (de) 2000-01-12 2001-01-11 Verwendung von tiludronsäure beim geflügel zur herstellung eines arzneimittels zur prophylaxe und behandlung von osteoporose

Country Status (15)

Country Link
US (1) US6482809B1 (de)
EP (1) EP1129714B1 (de)
JP (1) JP2001199891A (de)
AT (1) ATE306273T1 (de)
AU (1) AU783667B2 (de)
CZ (1) CZ2001135A3 (de)
DE (1) DE60113895T2 (de)
DK (1) DK1129714T3 (de)
ES (1) ES2249396T3 (de)
FR (1) FR2803521B1 (de)
HU (1) HUP0100122A3 (de)
IL (1) IL140839A0 (de)
NZ (1) NZ509285A (de)
SK (1) SK286583B6 (de)
ZA (1) ZA200100289B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ301143B6 (cs) * 2005-03-10 2009-11-18 Koropecký@Igor Zpusob získávání koncentrovaného glycerolu a smesi vyšších mastných kyselin z glycerinové fáze, vznikající pri výrobe bionafty

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014455A1 (en) * 1992-12-23 1994-07-07 Merck & Co., Inc. Bisphosphonate/estrogen therapy for treating and preventing bone loss
EP0950417A3 (de) * 1998-02-23 2000-02-23 Pfizer Products Inc. Behandlung von Skeletterkrankungen
EP1210138A4 (de) * 1999-04-22 2003-05-07 Hydro Med Sciences Inc Kontrollierte verabreichung von bisphosphonaten

Also Published As

Publication number Publication date
DE60113895T2 (de) 2006-06-22
DE60113895D1 (de) 2006-02-23
NZ509285A (en) 2002-05-31
JP2001199891A (ja) 2001-07-24
US6482809B1 (en) 2002-11-19
FR2803521A1 (fr) 2001-07-13
EP1129714A1 (de) 2001-09-05
ES2249396T3 (es) 2006-04-01
ZA200100289B (en) 2001-07-24
SK286583B6 (sk) 2009-01-07
DK1129714T3 (da) 2006-02-06
FR2803521B1 (fr) 2002-10-25
EP1129714B1 (de) 2005-10-12
HUP0100122A3 (en) 2003-02-28
SK552001A3 (en) 2001-08-06
HUP0100122A2 (hu) 2002-03-28
IL140839A0 (en) 2002-02-10
HU0100122D0 (en) 2001-03-28
AU1114101A (en) 2001-07-19
CZ2001135A3 (cs) 2001-08-15
AU783667B2 (en) 2005-11-24

Similar Documents

Publication Publication Date Title
IL171977A (en) Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same
EE05419B1 (et) Asendatud oksasolidinoonid kombineeritud raviks
GEP20032925B (en) Benzothiepines Having Activity As Inhibitors of Ileal Bile Acid Transport and Taurocholate Uptake
UA74346C2 (uk) Похідні амінодикарбонових кислот, їх застосування та лікарський засіб
ATE205086T1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
BR0116832A (pt) Produto desodorante, método cosmético e método de fabricação de composição desodorante
DE69507029D1 (de) Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten
ATE213164T1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
DE60207383D1 (de) Ibuprofen und diphenhydramin enthaltende zusammensetzungen und deren verwendung zur behandlung von schlafstörungen
BR0312000A (pt) Compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, uso dos compostos
DE59401401D1 (de) Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
ATE274916T1 (de) Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome
ATE192646T1 (de) Verwendung eines stoffgemisches enthaltend alpha hydroxy organische säure zur herstellung eines arzneimittels zur behandlung von kleinen mundgeschwüren
ATE439833T1 (de) Pharmazeutische zubereitung enthaltend ein catechin, ascorbinsäure, prolin und lysin zur behandlung von neoplastischen krankheiten
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
NZ334571A (en) Pharmaceutical composition comprising 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy-acetic acid for treating diseases induced by respiratory syncytial virus
ATE306273T1 (de) Verwendung von tiludronsäure beim geflügel zur herstellung eines arzneimittels zur prophylaxe und behandlung von osteoporose
DE60106890D1 (de) Verwendung von cdp-choline zur behandlung des alkoholentzugsyndroms
HK1049169B (zh) 取代的4-苄基氨基喹啉、其製備方法、含有這些化合物的藥物及其應用
SG129278A1 (en) A solid oral dosage form of metformin and glyburide and the method of preparation thereof
ATE337790T1 (de) Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen
ATE300304T1 (de) Verwendung von xanthinederivaten zur herstellung eines arzneimittels zur behandlung oder verhütung von osteoporose
ATE345124T1 (de) Verwendung von l-acetylcarnitin zur herstellung eines medikaments zur behandlung von anhedonia

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1129714

Country of ref document: EP

REN Ceased due to non-payment of the annual fee